Clinical Trials Browser

Completed × Interventional × Hematologic Tumors × Clear all

NCT00675350 2014-05-12

Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors

Phase 1 Completed

Hematologic Tumors